Biomednewsbreaks - Nanoviricides (NYSE American: NNVC) Reports Financials, Advances NV-387 Antiviral Trials
NanoViricides, Inc. (NYSE American: NNVC) has filed its quarterly report for the period ending Dec. 31, 2024, with the SEC, reporting cash and cash e ...
NanoViricides reports Q2 EPS (14c) vs. (18c) last year
The company said, “We reported that, as of December 31, 2024, we had cash and cash equivalent current assets balance of approximately $3.96 ...
NanoViricides, Inc. Has Filed its Quarterly Report
Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...
NanoViricides: Fiscal Q2 Earnings Snapshot
(NNVC) on Friday reported a loss of $2 million in its fiscal second quarter. On a per-share basis, the Shelton, Connecticut-based company said it had a loss of 14 cents. This story was generated by ...
Is NanoViricides Inc. (NNVC) the Best Nanotech Penny Stock to Invest In?
We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...
Pharmabiz7d
NanoViricides announces its antiviral drug, NV-387 can fight bird flu pandemic; H5N1 virus will not be able to escape even as it changes in the field
Shelton, Connecticut Thursday, February 13, 2025, 16:00 Hrs [IST] ...
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
Applied DNA Sciences, Inc. (NASDAQ:APDN) (”Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today issued a reminder to its shareholders to vote ahead of a reconvening of a ...
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
Mena FN9d
Biomednewsbreaks - Nanoviricides (NYSE American: NNVC) Claims NV-387 Ready To Combat Bird Flu
(MENAFN- Investor Brand Network) NanoViricides, Inc. (NYSE American: NNVC) announced its broad-spectrum antiviral NV-387 as a potential solution for combating H5N1 bird flu, stating that the virus is ...